MV Portfolios (MVP) 10-Q/A 29 Sep 14 2014 Q3 Quarterly report (amended) Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Mar. 31, 2014	Jul. 21, 2014
Document And Entity Information	'	'
Entity Registrant Name	'MV Portfolios, Inc.	'
Entity Central Index Key	'0001363573	'
Document Type	'10-Q	'
Document Period End Date	31-Mar-14	'
Amendment Flag	'true	'
Amendment Description	'MV Portfolios, Inc., formerly California Gold Corp., is filing this amendment (the "Amendment") to the Company's Form 10-Q for the period ended March 31, 2014 filed with the Securities Exchange Commission on July 23, 2014 (the "Original Report"), in order to provide restated unaudited consolidated financial statements and footnotes as discussed in Note 12 to the accompanying restated unaudited consolidated financial statements.	'
Current Fiscal Year End Date	'--06-30	'
Is Entity a Well-known Seasoned Issuer?	'No	'
Is Entity a Voluntary Filer?	'No	'
Is Entity's Reporting Status Current?	'Yes	'
Entity Filer Category	'Smaller Reporting Company	'
Entity Common Stock, Shares Outstanding	'	11,026,013	[1]
Document Fiscal Period Focus	'Q3	'
Document Fiscal Year Focus	'2014	'
[1]	Takes into account an anticipated reverse stock split on a 1 for 100 basis as further discussed in the Quarterly Report.

CONSOLIDATED_BALANCE_SHEETS_Un

CONSOLIDATED BALANCE SHEETS (Unaudited) (USD $)	Mar. 31, 2014		Jun. 30, 2013
Current assets:	'		'
Cash	$1,870,247	[1],[2]	$2,523	[3]
Cash held in escrow	25,299	[1],[2]	'	[3]
Assets held for sale from discontinued operations	19,341	[1],[2]	'	[3]
Deferred financing costs	1,082,242	[1],[2]	'	[3]
Total current assets	2,997,129	[1],[2]	2,523	[3]
Deferred offering costs	'	[1],[2]	38,500	[3]
Total assets	2,997,129	[1],[2]	41,023	[3]
Current liabilities:	'		'
Accounts payable and accrued expenses	177,769	[1],[2]	259,824	[3]
Contingent liabilities	'	[1],[2]	441,527	[3]
Derivative liabilities	3,530,995	[1],[2]	'	[3]
Convertible notes, net of unamortized discounts of $230,279	4,054,716	[1],[2]	'	[3]
Liabilities from discontinued operations	15,313	[1],[2]	'	[3]
Total current liabilities	7,778,793	[1],[2]	701,351	[3]
Long-term liabilities:	'		'
Accrued salaries, member	'	[1],[2]	435,516	[3]
Participation rights	'	[1],[2]	275,000	[3]
Total long-term liabilities	'	[1],[2]	710,516	[3]
Total liabilities	7,778,793	[1],[2]	1,411,867	[3]
Stockholders' deficit:	'		'
Preferred stock, par value $0.001 per share, 22,000,000 shares authorized; 16,000,000 shares issued and outstanding	16,000	[1],[2]	'	[3]
Common stock, par value $0.001 per share, 300,000,000 shares authorized; 10,946,013 shares issued and outstanding	165,486	[1],[2]	'	[3]
Additional paid-in capital	-238,674	[1],[2]	'	[3]
Deficit accumulated during the development stage	-4,724,476	[1],[2]	-1,370,844	[3]
Total stockholders' deficit	-4,781,664	[1],[2]	-1,370,844	[3]
Total liabilities and stockholders' deficit	$2,997,129	[1],[2]	$41,023	[3]
[1]	California Gold Corp. and Subsidiaries
[2]	Restated
[3]	MV Patents, LLC

CONSOLIDATED_BALANCE_SHEETS_Pa

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)	Mar. 31, 2014
Statement of Financial Position [Abstract]	'
Convertible notes, net of unamortized discounts	$230,279
Preferred stock, par value	$0.00
Preferred stock, shares authorized	22,000,000
Preferred stock, shares issued	16,000,000
Preferred stock, shares outstanding	16,000,000
Common stock, par value	$0.00
Common stock, shares authorized	300,000,000
Common stock, shares issued	10,946,013
Common stock, shares outstanding	10,946,013

CONSOLIDATED_STATEMENTS_OF_OPE

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) (USD $)	3 Months Ended			9 Months Ended			33 Months Ended
	Mar. 31, 2014		Mar. 31, 2013	Mar. 31, 2014		Mar. 31, 2013	Mar. 31, 2014
Operating Expenses:	'		'	'		'	'
General and administrative	$356,412	[1]	$237,667	$589,174	[1]	$578,561	$1,953,896	[1]
Acquisition related costs	1,472,706	[1]	'	1,472,706	[1]	'	1,472,706	[1]
Loss from operations	1,829,118	[1]	237,667	2,061,880	[1]	578,561	3,426,602	[1]
Other income (expenses):	'		'	'		'	'
Interest income	33	[1]	'	33	[1]	'	33	[1]
Interest expense	-404,994	[1]	-900	-413,335	[1]	-1,908	-419,457	[1]
Realized and unrealized loss on derivatives	-2,380,540	[1]	'	-2,380,540	[1]	'	-2,380,540	[1]
Total other income (expenses)	-2,785,501	[1]	-900	-2,793,842	[1]	-1,908	-2,799,964	[1]
Loss from continuing operations	-4,614,619	[1]	-238,567	-4,855,722	[1]	-580,469	-6,226,566	[1]
Loss from discontinued operations	-212,479	[1]	'	-212,479	[1]	'	-212,479	[1]
Net loss	($4,827,098)	[1]	($238,567)	($5,068,201)	[1]	($580,469)	($6,439,045)	[1]
Basic and diluted net loss per share:	'		'	'		'	'
Loss from continuing operations per share	($0.42)	[1]	$0	($0.44)	[1]	$0	'
Loss from discontinued operations per share	($0.02)	[1]	($0.21)	($0.02)	[1]	($0.50)	'
Net loss per share	($0.44)	[1]	($0.21)	($0.46)	[1]	($0.50)	'
Weighted average number of common shares outstanding - basic and diluted	10,918,321	[1]	1,161,804	10,918,321	[1]	1,161,804	'
[1]	Restated

CONSOLIDATED_STATEMENTS_OF_STO

CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Unaudited) (USD $)

Preferred Stock [Member]

Common Stock [Member]

Additional Paid-In Capital

Members Equity [Member]

Accumulated Deficit

Total

Beginning Balance, Amount at Jul. 10, 2011

[1]

'

'

'

'

'

'

Beginning Balance, Shares at Jul. 10, 2011

[1]

'

'

'

'

'

'

Net loss (Restated)

[1]

'

'

'

-483,967

'

-483,967

Ending Balance, Amount (Restated) at Jun. 30, 2012

[1]

'

'

'

-483,967

'

-483,967

Ending Balance, Shares (Restated) at Jun. 30, 2012

[1]

'

'

'

'

'

'

Net loss (Restated)

[1]

'

'

'

-886,877

'

-886,877

Ending Balance, Amount (Restated) at Jun. 30, 2013

[1]

'

'

'

-1,370,844

'

-1,370,844

Ending Balance, Shares (Restated) at Jun. 30, 2013

[1]

'

'

'

'

'

'

Warrants issued with debt

[1]

'

'

'

'

'

'

Reclassification of warrants to derivative liabilities

[1]

'

'

'

'

'

'

Stockholder contribution

[1]

'

'

'

150,000

'

'

Net loss (Restated)

[1]

'

'

'

-343,725

'

'

Ending Balance, Amount (Restated) at Feb. 06, 2014

[1]

'

'

'

-1,564,569

'

'

Ending Balance, Shares (Restated) at Feb. 06, 2014

[1]

'

'

'

'

'

'

Successor Beginning Balance, Shares

[2]

'

9,385,000

'

'

'

'

Successor Beginning Balance, Amount

[2]

'

9,385

-9,385

'

'

'

Shares issued in reverse merger, Shares (Restated)

[2]

22,000,000

1,501,013

'

'

'

'

Shares issued in reverse merger, Amount (Restated)

[2]

22,000

150,101

-1,351,259

'

'

-1,179,158

Conversion of Series A Preferred stock to common stock, Shares

[2]

-6,000,000

60,000

'

'

'

'

Conversion of Series A Preferred stock to common stock, Amount

[2]

-6,000

6,000

'

'

'

'

Warrants issued with debt

[2]

'

'

'

'

'

'

Warrants issued for deferred financing costs

[2]

'

'

1,120,970

'

'

'

Reclassification of warrants to derivative liabilities

[2]

'

'

'

'

'

'

Stockholder contribution

[2]

'

'

1,000

'

'

'

Net loss (Restated)

'

[2]

'

[2]

'

[2]

'

[2]

-4,724,476

[2]

-4,724,476

Ending Balance, Amount (Restated) at Mar. 31, 2014

[2]

$16,000

$165,486

($238,674)

'

($4,724,476)

($4,781,664)

[3]

Ending Balance, Shares (Restated) at Mar. 31, 2014

[2]

16,000,000

10,946,013

'

'

'

'

Conversion of Series A Preferred stock to common stock, Shares

8,000,000

80,000

'

'

'

'

Ending Balance, Amount (Restated) at Jul. 21, 2014

'

'

'

'

'

'

[1]

MV Patents, LLC

[2]

California Gold Corp. and Subsidiaries

[3]

Restated

CONSOLIDATED_STATEMENTS_OF_CAS

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) (USD $)	9 Months Ended			33 Months Ended
	Mar. 31, 2014		Mar. 31, 2013	Mar. 31, 2014
Cash flows from operating activities:	'		'	'
Net loss	($5,068,201)	[1]	($580,469)	($6,439,045)	[1]
Adjustments to reconcile net loss to net cash flows used in operating activities:	'		'	'
Depreciation	294		'	294
Amortization of debt discounts and deferred financing	347,068		'	347,068
Change in derivative liabilities	2,380,540		'	2,380,540
Settlement of legal fees through the issuance of convertible notes	25,000		'	25,000
Changes in operating assets and liabilities:	'		'	'
Cash held in escrow	-25,799		'	-25,799
Prepaid assets	-423		'	-423
Deferred offering costs	38,500		'	'
Accounts payable and accrued expenses	98,160		75,836	357,984
Accrued salaries, member	140,591		168,947	576,107
Other liabilities	10,000		'	10,000
Contingent liabilities	'		182,500	441,527
Net cash used in operating activities	-2,054,270		-153,186	-2,326,747
Cash flows from investing activities:	'		'	'
Cash received in reverse merger	209,392		'	209,392
Net cash provided by investing activities	209,392		'	209,392
Cash flows from financing activities:	'		'	'
Cash paid for debt issuance costs	-295,150		'	-295,150
Proceeds from issuing convertible notes	3,934,995		'	3,934,995
Proceeds from demand note	50,000		'	50,000
Proceeds from participation notes	20,000		115,000	295,000
Contribution	2,757		'	2,757
Net cash provided by financing activities	3,712,602		115,000	3,987,602
Net increase (decrease) in cash	1,867,724		-38,186	1,870,247
Cash, beginning of period	2,523	[2]	39,520	'
Cash, end of period	1,870,247	[1],[3]	1,334	1,870,247	[1],[3]
Supplemental disclosures of cash flow information:	'		'	'
Interest paid	'		'	'
Income taxes paid	'		'	'
Non-cash investing and financing activities:	'		'	'
Shares issued in reverse merger, net of cash received	1,388,550		'	1,388,550
Conversion of Series A Preferred stock to common stock	6,000		'	6,000
Warrants issued for deferred financing costs	$1,120,970		'	$1,120,970
[1]	Restated
[2]	MV Patents, LLC
[3]	California Gold Corp. and Subsidiaries

Interim_Financial_Statements

Interim Financial Statements	9 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Interim Financial Statements	'
	The unaudited consolidated financial statements of California Gold Corp. (“California Gold”) and Subsidiaries (collectively, the “Company”) as of March 31, 2014 and for the three and nine month periods ended March 31, 2014 and 2013 have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in annual financial statements prepared in accordance with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.
	The consolidated balance sheet of MV Patents, LLC (“MV Patents”) at June 30, 2013 has been derived from the audited financial statements at that date, but does not include all of the information and notes required by accounting principles generally accepted in the United States for complete financial statements. All adjustments that, in the opinion of management, are necessary for a fair presentation for the periods presented have been reflected as required by the SEC. Such adjustments are of a normal, recurring nature. It is suggested that these unaudited consolidated financial statements be read in conjunction with the financial statements and notes thereto of MV Patents for the year ended June 30, 2013 included as Exhibit 99.1 on Form 8-K filed by the Company on March 10, 2014.  The results of operations for interim periods are not necessarily indicative of the operating results to be expected for the full year or any other interim period.

Nature_of_Business_Share_Excha

Nature of Business, Share Exchange, and Development Stage Activities	9 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Nature of Business, Share Exchange, and Development Stage Activities	'
	California Gold was an exploration stage mining company with a focus on the identification, acquisition and development of rare and precious metals mining properties in the Americas. On February 7, 2014, the Company entered into a securities exchange agreement (the “Securities Exchange”) with MVP Portfolio, LLC, a Florida limited liability company (“MVP Portfolio”), MV Patents, a Florida limited liability company and majority member of MVP Portfolio, and other members of MVP Portfolio (all such members collectively, the “Members”). Pursuant to the Securities Exchange, the Members sold all of their membership interests in MVP Portfolio to the Company in exchange for an aggregate of 9,385,000 shares of common stock, $0.001 par value per share, after taking into account an anticipated 1 for 100 reverse stock split (the “Reverse Split”) of the Company’s issued and outstanding common stock on a one for one hundred basis. Following the Securities Exchange, the Company assumed the additional line of business of MVP Portfolio.
	The Securities Exchange was consummated in anticipation of a 1 for 100 Reverse Split. As of the date of the filing of this Form 10Q, the Reverse Split has not been effected. As the Securities Exchange is dependent upon the Reverse Split, all share and per share amounts herein have been retroactively restated to reflect the 1 for 100 Reverse Split as if it has been effected.
	MV Patents, formed on July 11, 2011, is in the developmental stage, and has limited operations. MVP Portfolio was formed on July 26, 2013 as a wholly owned subsidiary of MV Patents. On August 30, 2013, MV Patents transferred a portion of its patents without recourse to MVP Portfolio.  Pursuant to the Securities Exchange on February 7, 2014, MVP Portfolio ceased to be a subsidiary of MV Patents and became a wholly owned subsidiary of California Gold. MV Patents is deemed to be the predecessor entity to MVP Portfolio.
	On March 6, 2014, MVP Portfolio changed its form of organization to a Florida corporation from a Florida limited liability company, and changed its name to Visual Real Estate, Inc. (“VRE”). VRE has historically maintained a June 30 fiscal year, through MV Patents, the predecessor business to MVP Portfolio.
	VRE is a development stage company engaged in the business of patent licensing and assertion of rights under patents against parties believed to be selling goods or services that rely upon VRE’s patented technology. VRE owns a patent portfolio it refers to as “Video Drive-by” and online mapping, which has previously been used by its predecessors and licensees commercially. VRE currently owns a patent portfolio consisting of eight (8) issued and sixteen (16) pending patents. The patents disclose systems and methods for providing video drive-by data to enable a street level view of a neighborhood surrounding a geographic location. The systems include, generally, a video and data server farm incorporating at least one (1) video storage server that stores video image files containing video drive-by data corresponding to a geographic location, a data base server that processes a data query received from a user over the internet and an image processing server.
	The financial position, operating results and cash flows presented herein for the periods prior to February 7, 2014, represent those of MV Patents, the predecessor entity. The financial position, operating results and cash flows presented herein for the periods subsequent to February 6, 2014, represent those of the Company and VRE (formerly MVP Portfolio), collectively the successor entity.  The ongoing business of VRE is still in the development stage and has generated no revenues to date.
	Results of operations from February 7, 2014 through March 31, 2014 include the pre-Securities Exchange business unrelated to VRE, which is reflected as discontinued operations in the consolidated financial statements, and the business of VRE.  The results of operations for the three months ended March 31, 2014 includes the combined results of operations of MV Patents from January 1, 2014 through February 6, 2014 and the consolidated results of operations of California Gold and Subsidiaries (including (i) CalGold de Mexico, S. de R.L. de C.V., formed to explore mining opportunities in Mexico, and included in discontinued operations as of and for the periods ending March 31, 2014 and (ii) VRE) for the period February 7, 2014 through March 31, 2014. The results of operations for the nine months ended March 31, 2014 includes the combined results of operations of MV Patents from July 1, 2013 through February 6, 2014 and the consolidated results of operations of California Gold and Subsidiaries for the period February 7, 2014 through March 31, 2014.
	Results of operations for the three month and nine month periods ended March 31, 2013 includes the results of operations of MV Patents, as the predecessor business to VRE.
	The Securities Exchange was accounted for as a reverse recapitalization, such that MVP Portfolio (VRE as of March 6, 2014), the legal acquiree, is considered the acquirer for accounting purposes and VRE is treated as the surviving and continuing entity. Pursuant to the Securities Exchange, the pre-Securities Exchange exploration stage mining business will be discontinued, and the business of VRE will be continued. In addition, VRE’s management has assumed operational, management and governance control of the Company. The accounting for a reverse recapitalization is similar to that resulting from a reverse acquisition, except that no goodwill or other intangible assets should be recorded. The fair value of the consideration effectively transferred in a reverse recapitalization is equal to the net tangible assets (liabilities) assumed. The net liabilities of California Gold retained subsequent to the transaction are as follows:
	Cash	$	209,392
	Other assets		18,712
	Accounts payable and accrued expenses		(168,325	)
	Notes payable		(88,482	)
	Derivative liabilities		(1,150,455	)
	Net liabilities retained	$	(1,179,158	)
	Subsequent to the Securities Exchange, the Company changed the fiscal year end of California Gold to June 30, which is VRE’s year end.
	The ongoing business plan of the Company is to assert its intellectual property rights to monetize its patents through net recoveries. Net recoveries relate to monetary payments received by the Company in respect to its patents through judgments, settlements, royalty agreements, or other disposition of the patents or cash proceeds of any equity actually received as consideration for any such disposition, including those received in connection with litigation.
	The Company has no technologies or technology operations.

Going_Concern

Going Concern	9 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Going Concern	'
	The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business.  As shown in the condensed consolidated financial statements, the Company is currently in the development stage with losses for all periods presented.   The Company has not established an ongoing source of revenues and has funded activities to date primarily from convertible notes offerings.  These conditions raise substantial doubt about the Company’s ability to continue as a going concern.
	The Company is subject to a number of risks similar to other companies in the development stage, including, but not limited to, the need to obtain adequate funding and possible risk of failure to monetize its patents. If the Company does not successfully monetize its patents, it will be unable to generate revenues or achieve profitability.
	Management’s plan with respect to funding this development is to secure equity financing through access to U.S. capital markets as a registrant of the U.S. Securities and Exchange Commission.
	While the Company believes it will be successful in obtaining the necessary financing to (i) fund its operations, (ii) monetize its patents and meet revenue projections and (iii) manage costs,  it does not currently have any financing plans in place and there are no assurances that such additional funding will be achieved and that it will succeed in its future operations. The consolidated financial statements do not include any adjustments relating to the recoverability and classification of recorded asset amounts or amounts of liabilities that might be necessary should the Company be unable to continue as a going concern. Operating results for the three and nine month periods ended March 31, 2014, are not necessarily indicative of the results that may be expected for the fiscal year ending June 30, 2014.

Discontinued_Operations

Discontinued Operations	9 Months Ended
	Mar. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Discontinued Operations	'
	Pursuant to the Securities Exchange, the pre-existing exploration stage mining business will be discontinued. The Company plans on transferring the pre-Securities Exchange assets and liabilities related to the historical business which existed prior to the acquisition of MVP Portfolio to a to-be-formed wholly owned subsidiary. The Company plans to seek a buyer for the to-be-formed wholly owned subsidiary and/or the assets and liabilities of such business.
	The following table presents summarized operating results for these discontinued operations for the pre-Securities Exchange business. The table below does not present the results of operations of MV Patents because the historical financial information represents the activity of MV Patents as the predecessor business to VRE, and does not include any of the operations of the discontinued exploration stage mining business.  The historical financial information for MV Patents for the three and nine month periods ended March 31, 2013 is included in the accompanying consolidated financial statements.
		February 7, 2014 Through
		31-Mar-14
	Loss from discontinued operations	$	(212,479	)
	Components of assets and liabilities from discontinued operations consist of the following as of March 31, 2014. The table does not present the discontinued assets and liabilities as of June 30, 2013 because the June 30, 2013 historical financial information represents the activity of MV Patents as the predecessor business to VRE, while the discontinued operations relates specifically to the pre-existing exploration stage mining business.
	Current assets:
	Cash held in escrow	$	500
	Prepaid assets		14,793
	Total current assets		15,293
	Noncurrent assets:
	Property and equipment, net		4,048
	Total assets from discontinued operations	$	19,341
	Current liabilities:
	Accounts payable and accrued liabilities	$	15,313
	Total current liabilities		15,313
	Total liabilities from discontinued operations	$	15,313

Convertible_Notes

Convertible Notes	9 Months Ended
	Mar. 31, 2014
Debt Disclosure [Abstract]	'
Convertible Notes	'
	On February 7, 2014 (the “February 2014 Offering”) and March 3, 2014 (the “March 2014 Offering”), the Company held two separate closings of private placement offerings pursuant to which it sold to various accredited investors (collectively, the “Investors”) $2,942,495 and $992,500 (before deducting placement agent fees and expenses of the offering), respectively, in principal amount of its 10% convertible promissory notes (the “Notes”). An additional $25,000 of the Notes was issued for the settlement of legal fees during the period from February 7, 2014 through March 31, 2014. The Notes mature within one year from the date of issuance.
	The Notes will automatically convert into shares of the Company’s to-be authorized Series C Convertible Preferred Stock, $0.001 par value per share (the “Series C Preferred Stock”), at a pre-Reverse Split conversion price of $0.005 per share and a post-Reverse Split conversion price of $0.50 per share (the “Conversion Price”), upon the Company’s filing of a Certificate of Designation of Series C Convertible Preferred Stock (the “Certificate of Series C Designation”) with the Secretary of State of the State of Nevada following completion of the proxy voting process to increase our authorized preferred stock, and which Series C Preferred Stock shall be convertible into shares of the Company’s Common Stock on a one share for one share basis. The Company evaluated the shares and determined a contingent beneficial conversion feature of $3,959,995 existed within this transaction. The beneficial conversion is contingent upon the filing of the Series C Convertible Preferred Stock Designation, and the Reverse Split. The beneficial conversion amount related to the value of the Notes will be accreted back to the Notes in accordance with the requirements of FASB ASC Topic 470-20, Accounting for Debt Instruments with Specific Conversion Features, when the contingency is met.
	Also in connection with the February and March 2014 Offerings, the Company paid cash of $295,150 and issued an aggregate of 590,300 warrants (post 1 for 100 Reverse Split) as payment of commissions. The Warrants entitle the holder to purchase shares of Common Stock at an exercise price of $0.50 per share and will be exercisable for three (3) years from the date of issuance. The fair value of the warrants was determined to be $1,120,970. The warrants and the cash commissions were recorded as deferred financing costs which are being amortized to interest expense over the life of the Notes using the effective interest method. Amortization of $333,878 was recorded against these deferred financing costs during the period from February 7, 2014 through March 31, 2014.
	During the period from February 7, 2014 through March 31, 2014, additional amortization expense of $13,190 was recognized associated with the debt discounts related to the outstanding notes originally issued in November 2013. The unamortized discount associated with these notes was $230,279 as of March 31, 2014.

Derivative_Liabilities

Derivative Liabilities	9 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
Derivative Liabilities	'
	As of February 7, 2014 and March 31, 2014, there were 2,965,704 (post 1 for 100 Reverse Split) outstanding derivative warrants with 1,482,852 common shares issuable upon exercise. The warrants qualify as derivative liabilities due to the existence of reset provisions which cause the instruments to no longer be indexed to the Company’s own stock under FASB ASC Topic 815, Derivatives and Hedging. The estimated fair value of the derivative warrants were calculated using the Black-Scholes option pricing model as of March 31, 2014. The fair value of the warrants was determined to be $1,150,455 and $3,530,995 as of February 7, 2014 and March 31, 2014, respectively. The company recorded a $2,380,540 loss on the change in fair value as non-operating expense for the period from February 7, 2014 through March 31, 2014.
	The range of significant assumptions used in the Black-Scholes option pricing model as of March 31, 2014 were as follows (post 1 for 100 Reverse Split):
		Range
	Common stock issuable upon exercise of warrants		1,482,852
	Exercise price		$0.90 - $1.60
	Market price of the Company’s common stock		$2.40
	Risk free interest rate		0.44% - 0.69%
	Dividend yield		0%
	Volatility		357.70% - 381.34%
	Expected term	1.73 - 2.96 years
	Fair Value Measurements
	The Company measures its financial assets and liabilities in accordance with the requirements of FASB ASC Topic 820, Fair Value Measurements and Disclosures. FASB ASC Topic 820 defines fair value, establishes a framework for measuring fair value in accordance with generally accepted accounting principles, and expands disclosures about fair value measurements. ASC 820 establishes a three-tier fair value hierarchy which prioritizes the inputs used in measuring fair value as follows:
	Level 1.  Observable inputs such as quoted prices in active markets;
	Level 2.  Inputs, other than the quoted prices in active markets, that are observable either directly or indirectly; and
	Level 3.  Unobservable inputs in which there is little or no market data, which requires the reporting entity to develop its own assumptions.
	The Company uses Level 3 inputs to estimate the fair value of its derivative liabilities.
	The following table sets forth the fair value hierarchy within our financial assets and liabilities by level that they were accounted for at fair value on a recurring basis as of March 31, 2014 and June 30, 2013:
		Fair Value Measurement at March 31, 2014
			Level 1		Level 2		Level 3
	Liabilities:
	Warrant derivative liabilities	$	—	$	—	$	3,530,995
	Total	$	—	$	—	$	3,530,995
		Fair Value Measurement at June 30, 2013
			Level 1		Level 2		Level 3
	Liabilities:
	None	$	—	$	—	$	—
	Total	$	—	$	—	$	—
	The following table sets forth the changes in the fair value of derivative liabilities for the period from February 7, 2014 through March 31, 2014:
	Balance, February 7, 2014	$	1,150,445
	Change in fair value of derivative liabilities		2,380,540
	Balance, March 31, 2014	$	3,530,995

Stock_Options_and_Warrants

Stock Options and Warrants	9 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Stock Options and Warrants	'
	Options
	On February 7, 2014, the Company’s Board of Directors voted to terminate the 2007 Stock Option Plan and adopted the 2014 Equity Incentive Plan (the “2014 Plan”), which provides for the issuance of incentive awards of up to 6,150,564 post 1 for 100 Reverse Split shares of the Company’s Common Stock to officers, key employees, consultants and directors.  The options’ exercise price will be no less than the closing price of the Company’s shares on the day of issuance. When incentive stock options are granted to an employee who, at the time the incentive stock option is granted, owns stock representing more than 10% of the voting power of all classes of stock of the Company, the per share exercise price will be no less than 110% of the closing price of the Company’s shares on the day of issuance.
	The Company has 6,150,564 options available for grant under the 2014 Plan. As of March 31, 2014, there were no stock options outstanding.
	Warrants
	The following table presents the warrant activity during the period from February 7, 2014 through March 31, 2014 presented on a post 1 for 100 reverse split basis:
		Common Shares	Weighted Average Exercise Price		Weighted Average Remaining Term (Years)	Aggregate Intrinsic Value
		Covered by Warrants
	Outstanding at February 7, 2014	1,482,852	$	1.088	2.018
	Granted	590,300		0.5	3
	Outstanding at March 31, 2014	2,073,152	$	0.92	2.16	$4,104,125
	Exercisable at March 31, 2014	2,073,152	$	0.92	2.16	$4,104,125

Stockholders_Equity

Stockholders' Equity	9 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
Stockholders' Equity	'
	On February 6, 2014, the Company entered into warrant exchange agreements related to 3,250,000 warrants originally issued with convertible notes in November 2013. The warrants were cancelled and exchanged for the right to receive, upon effectiveness of the Reverse Split, 4,000,000 shares of the Company’s common stock.
	A related party stockholder, purchased 6,000,000 units of the Company’s Preferred Series A Stock in the Company’s 2010/2011 Private Placement for an aggregate investment of $150,000. Such stockholder converted the 6,000,000 units of Preferred Series A Stock to 60,000 shares of the Company’s common stock on February 28, 2014.
	During the period from February 7, 2014 through March 31, 2014, a stockholder contributed $1,000 to the Company.

Related_Party_Transactions

Related Party Transactions	9 Months Ended
	Mar. 31, 2014
Related Party Transactions [Abstract]	'
Related Party Transactions	'
	As of March 31, 2014, the Company owed its officers and directors $12,746 for compensation which was recorded as accounts payable and accrued liabilities in its consolidated balance sheets. As of June 30, 2013, MV Patents owed its officers and directors $435,516, which was recorded as accrued salaries – member in its consolidated balance sheets.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	The Company has employment agreements with two employees and a separate consulting agreement with one of the Company’s executive officers. The aggregate future commitment under these agreements is as follows:
	Twelve Months ending March 31,
	2015	$	203,333
	2016		143,333
	2017		122,431
		$	469,097
	These agreements provide for additional bonus payments that are calculated as defined.
	The Company is involved in various legal proceedings and litigation arising in the ordinary course of business. In the opinion of management and legal counsel, the outcome of such proceedings and litigation will not have a material adverse effect on the Company's condensed consolidated financial statements.
	Pursuant to the Securities Exchange the Company agreed to pay the members of MV Patents ten (10%) percent of the net proceeds to be received from any enforcement activities or sales transactions related to the patents owned or applications pending as of the closing of the Securities Exchange.

Subsequent_Events

Subsequent Events	9 Months Ended
	Mar. 31, 2014
Subsequent Events [Abstract]	'
Subsequent Events	'
	During May 2014, the Company issued an aggregate of 80,000 (post 1 for 100 reverse split) common shares for the conversion of 8,000,000 shares of Series A Preferred stock.
	On April 28, 2014 the Company notified Mexivada Mining Corp. and Compania Minera Mexivada S.A de C.V., of termination of the Mexivada Property Option Agreement dated as of February 11, 2011, as amended October 24, 2011, and that the Company would not pay any further fees or expenses associated with the Agreement.  As a result, the Company continues to own a 20% interest in 2 exploration mineral concessions, La Viuda and La Viuda 1, situated in the Municipality of Montezuma, Sonora, Mexico.

Correction_of_Previously_Repor

Correction of Previously Reported Information	9 Months Ended
	Mar. 31, 2014
Accounting Changes and Error Corrections [Abstract]	'
Correction of Previously Reported Information	'
	During the audit of the Company’s consolidated financial statements for the year ended June 30, 2014, the Company identified an error in the accounting for and presentation of the impact of the November 15, 2103 private placement offering (“November Offering”) on the Company’s derivative liability as of January 31, 2014 and March 31, 2014. In the November Offering, the Company issued warrants (“November 2013 Warrants”) entitling the Investors to purchase one thousand (1,000) shares of common stock for each $1.00 principal amount of consideration received, at an exercise price of $0.10 per share. Since the exercise price per share of the November 2013 Warrants was lower than the $3.00 warrant exercise prices of the warrants issued during the 2010/2011 private placement offerings, and the $6.00 exercise price of the warrants issued in the 2012 private placement offering, the exercise prices with respect to these previous warrant issuances should have been lowered, and the amount of shares exercisable increased based on the reset provisions in each warrant agreement. The Company did not account for the reset provisions in the previously reported consolidated financial statements as of January 31, 2014, and therefore the amounts accounted for as assumed net liabilities in the February 6, 2014 Reverse Recapitalization (Note 2) were recorded erroneously as of March 31, 2014. In addition the amount calculated as the fair market value for the derivative liabilities as of March 31, 2014 did not properly account for the change in exercise price and number of exercisable shares for the warrants from the 2010-2012 private placement offerings, as reset by the November Offering.
	In accordance with the SECs Staff Accounting Bulletin Nos. 99 and 108 (“SAB 99” and “SAB 108”), the Company evaluated this error and, based on an analysis of quantitative and qualitative factors, determined that the error is material to the March 31, 2014 period. Therefore, as permitted by SAB 108, the Company corrected, in the current filing, previously reported results for the period ended March 31, 2014.
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated balance sheet for the year ended March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Liabilities and stockholders’ deficit:
	Derivative liability	$	986,905		$	2,544,090		$	3,530,995
	Additional paid-in capital		587,139			(825,813	)		(238,674	)
	Deficit accumulated during the exploration stage	-3,006,199		-1,718,277	-4,724,476
	Total liabilities and stockholders’ deficit		2,997,129			—			2,997,129
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated statement of expenses for the three months ended March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Loss from operations:	$	(1,829,118	)		—		$	(1,829,118	)
	Other income (expenses):
	Realized and unrealized loss on derivatives		(662,263	)		(1,718,277	)		(2,380,540	)
	Total other income (expenses)		(1,067,224	)		(1,718,277	)		(2,785,501	)
	Loss from continuing operations		(2,896,342	)		(1,718,277	)		(4,614,619	)
	Loss from discontinued operations		(212,479	)		—			(212,479	)
	Net loss		(3,108,821	)		(1,718,277	)		(4,827,089	)
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated statement of expenses for the nine months ended March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Loss from operations:	$	(2,061,880	)		—		$	(2,061,880	)
	Other income (expenses):
	Realized and unrealized loss on derivatives		(662,263	)		(1,718,277	)		(2,380,540	)
	Total other income (expenses)		(1,075,565	)		(1,718,277	)		(2,793,842	)
	Loss from continuing operations		(3,137,445	)		(1,718,277	)		(4,855,722	)
	Loss from discontinued operations		(212,479	)		—			(212,479	)
	Net loss		(3,349,924	)		(1,718,277	)		(5,068,201	)
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated statement of expenses for the period July 11, 2011 (Inception) through March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Loss from operations:	$	(3,426,602	)		—		$	(3,426,602	)
	Other income (expenses):
	Realized and unrealized loss on derivatives		(662,263	)		(1,718,277	)		(2,380,540	)
	Total other income (expenses)		(1,081,687	)		(1,718,277	)		(2,799,964	)
	Loss from continuing operations		(4,508,289	)		(1,718,277	)		(6,226,566	)
	Loss from discontinued operations		(212,479	)		—			(212,479	)
	Net loss		(4,720,768	)		(1,718,277	)		(6,493,045	)
	In addition to the information noted above the correction of the previously reported information impacted the Company’s loss from continuing operations per share to $0.42 from $0.27 and to $0.44 from $0.29 for the three and nine months ended March 31, 2014, respectively.

Nature_of_Business_Share_Excha1

Nature of Business, Share Exchange, and Development Stage Activities (Tables)	9 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Net liabilities retained subsequent to transaction	'
	Cash	$	209,392
	Other assets		18,712
	Accounts payable and accrued expenses		(168,325	)
	Notes payable		(88,482	)
	Derivative liabilities		(1,150,455	)
	Net liabilities retained	$	(1,179,158	)

Discontinued_Operations_Tables

Discontinued Operations (Tables)	9 Months Ended
	Mar. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'
Loss from discontinued operations and assets and liabilities acquired	'
		February 7, 2014 Through
		31-Mar-14
	Loss from discontinued operations	$	(212,479	)
	Current assets:
	Cash held in escrow	$	500
	Prepaid assets		14,793
	Total current assets		15,293
	Noncurrent assets:
	Property and equipment, net		4,048
	Total assets from discontinued operations	$	19,341
	Current liabilities:
	Accounts payable and accrued liabilities	$	15,313
	Total current liabilities		15,313
	Total liabilities from discontinued operations	$	15,313
	5

Derivative_Liabilities_Tables

Derivative Liabilities (Tables)	9 Months Ended
	Mar. 31, 2014
Notes to Financial Statements	'
Fair value assumptions	'
		Range
	Common stock issuable upon exercise of warrants		1,482,852
	Exercise price		$0.90 - $1.60
	Market price of the Company’s common stock		$2.40
	Risk free interest rate		0.44% - 0.69%
	Dividend yield		0%
	Volatility		357.70% - 381.34%
	Expected term	1.73 - 2.96 years
Fair Value Hierarchy	'
		Fair Value Measurement at March 31, 2014
			Level 1		Level 2		Level 3
	Liabilities:
	Warrant derivative liabilities	$	—	$	—	$	3,530,995
	Total	$	—	$	—	$	3,530,995
		Fair Value Measurement at June 30, 2013
			Level 1		Level 2		Level 3
	Liabilities:
	None	$	—	$	—	$	—
	Total	$	—	$	—	$	—
Changes in fair value of derivative liabilities	'
	Balance, February 7, 2014	$	1,150,455
	Change in fair value of derivative liabilities		2,380,540
	Balance, March 31, 2014	$	3,530,995

Stock_Options_and_Warrants_Tab

Stock Options and Warrants (Tables)	9 Months Ended
	Mar. 31, 2014
Equity [Abstract]	'
Warrant activity	'
		Common Shares	Weighted Average Exercise Price		Weighted Average Remaining Term (Years)	Aggregate Intrinsic Value
		Covered by Warrants
	Outstanding at February 7, 2014	1,482,852	$	1.088	2.018
	Granted	590,300		0.5	3
	Outstanding at March 31, 2014	2,073,152	$	0.92	2.16	$4,104,125
	Exercisable at March 31, 2014	2,073,152	$	0.92	2.16	$4,104,125

Commitments_and_Contingencies_

Commitments and Contingencies (Tables)	9 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Aggregate future commitment under employment agreements	'
	Twelve Months ending March 31,
	2015	$	203,333
	2016		143,333
	2017		122,431
		$	469,097

Correction_of_Previously_Repor1

Correction of Previously Reported Information (Tables)	9 Months Ended
	Mar. 31, 2014
Accounting Changes and Error Corrections [Abstract]	'
Effect of correction of previously reported information	'
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated balance sheet for the year ended March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Liabilities and stockholders’ deficit:
	Derivative liability	$	986,905		$	2,544,090		$	3,530,995
	Additional paid-in capital		587,139			(825,813	)		(238,674	)
	Deficit accumulated during the exploration stage	-3,006,199		-1,718,277	-4,724,476
	Total liabilities and stockholders’ deficit		2,997,129			—			2,997,129
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated statement of expenses for the three months ended March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Loss from operations:	$	(1,829,118	)		—		$	(1,829,118	)
	Other income (expenses):
	Realized and unrealized loss on derivatives		(662,263	)		(1,718,277	)		(2,380,540	)
	Total other income (expenses)		(1,067,224	)		(1,718,277	)		(2,785,501	)
	Loss from continuing operations		(2,896,342	)		(1,718,277	)		(4,614,619	)
	Loss from discontinued operations		(212,479	)		—			(212,479	)
	Net loss		(3,108,821	)		(1,718,277	)		(4,827,089	)
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated statement of expenses for the nine months ended March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Loss from operations:	$	(2,061,880	)		—		$	(2,061,880	)
	Other income (expenses):
	Realized and unrealized loss on derivatives		(662,263	)		(1,718,277	)		(2,380,540	)
	Total other income (expenses)		(1,075,565	)		(1,718,277	)		(2,793,842	)
	Loss from continuing operations		(3,137,445	)		(1,718,277	)		(4,855,722	)
	Loss from discontinued operations		(212,479	)		—			(212,479	)
	Net loss		(3,349,924	)		(1,718,277	)		(5,068,201	)
	The following table presents the effect of the correction of the previously reported information and the impact on the Company’s unaudited consolidated statement of expenses for the period July 11, 2011 (Inception) through March 31, 2014:
		As of March 31, 2014
		As Previously			Adjustments			As Restated
		Reported
	Loss from operations:	$	(3,426,602	)		—		$	(3,426,602	)
	Other income (expenses):
	Realized and unrealized loss on derivatives		(662,263	)		(1,718,277	)		(2,380,540	)
	Total other income (expenses)		(1,081,687	)		(1,718,277	)		(2,799,964	)
	Loss from continuing operations		(4,508,289	)		(1,718,277	)		(6,226,566	)
	Loss from discontinued operations		(212,479	)		—			(212,479	)
	Net loss		(4,720,768	)		(1,718,277	)		(6,493,045	)
	In addition to the information noted above the correction of the previously reported information impacted the Company’s loss from continuing operations per share to $0.42 from $0.27 and to $0.44 from $0.29 for the three and nine months ended March 31, 2014, respectively.

Nature_of_Business_Share_Excha2

Nature of Business, Share Exchange, and Development Stage Activities (Details) (USD $)	Feb. 07, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Cash	$209,392
Other assets	18,712
Accounts payable and accrued expenses	-168,325
Notes payable	-88,485
Derivative liabilities	-1,150,455
Net liabilities retained	($1,179,158)

Nature_of_Business_Share_Excha3

Nature of Business, Share Exchange, and Development Stage Activities (Details Narrative) (USD $)	2 Months Ended
	Mar. 31, 2014
Organization, Consolidation and Presentation of Financial Statements [Abstract]	'
Sale of shares for reverse merger	9,385,000
Sale of shares for reverse merger, value per share	$0.00
Reverse stock split	'1 for 100

Discontinued_Operations_Detail

Discontinued Operations (Details) (USD $)	3 Months Ended			9 Months Ended			33 Months Ended
	Mar. 31, 2014		Mar. 31, 2013	Mar. 31, 2014		Mar. 31, 2013	Mar. 31, 2014
Discontinued Operations and Disposal Groups [Abstract]	'		'	'		'	'
Loss from discontinued operations	($212,479)	[1]	'	($212,479)	[1]	'	($212,479)	[1]
Current assets:	'		'	'		'	'
Cash held in escrow	500		'	500		'	500
Prepaid assets	14,793		'	14,793		'	14,793
Total current assets	15,293		'	15,293		'	15,293
Noncurrent assets:	'		'	'		'	'
Property and equipment, net	4,048		'	4,048		'	4,048
Total assets from discontinued operations	19,341		'	19,341		'	19,341
Current liabilities:	'		'	'		'	'
Accounts payable and accrued liabilities	15,313		'	15,313		'	15,313
Total current liabilities	15,313		'	15,313		'	15,313
Total liabilities from discontinued operations	$15,313		'	$15,313		'	$15,313
[1]	Restated

Convertible_Notes_Details_Narr

Convertible Notes (Details Narrative) (USD $)	2 Months Ended	9 Months Ended		33 Months Ended
	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2013	Mar. 31, 2014
Settlement of legal fees through the issuance of convertible notes	'	$25,000	'	$25,000
Preferred stock, par value	$0.00	$0.00	'	$0.00
pre-Reverse Split conversion price	$0.50	$0.50	'	$0.50
Fair value of warrants	313,670	313,670	'	313,670
Amortization	100,935	'	'	'
Cash paid for offering fees	'	295,150	'	295,150
Private Placement 1 [Member]	'	'	'	'
Offering Date	7-Feb-14	'	'	'
Proceeds from private placements	2,942,495	'	'	'
Convertible note issued, rate	10.00%	10.00%	'	10.00%
Warrants issued with private placements	29,424,950	'	'	'
Warrant exercise price	$0.10	$0.10	'	$0.10
Exercise term	'10 years	'	'	'
Private Placement 2 [Member]	'	'	'	'
Offering Date	3-Mar-14	'	'	'
Proceeds from private placements	992,500	'	'	'
Convertible note issued, rate	10.00%	10.00%	'	10.00%
Warrants issued with private placements	10,175,000	'	'	'
Warrant exercise price	$0.10	$0.10	'	$0.10
Exercise term	'10 years	'	'	'
Agent Fees [Member]	'	'	'	'
Warrant exercise price	$0.50	$0.50	'	$0.50
Exercise term	'3 years	'	'	'
Fair value of warrants	5,166	5,166	'	5,166
Amortization	$79,412	'	'	'
Warrants issued for offering fees	590,300	'	'	'

Derivative_Liabilities_Details

Derivative Liabilities (Details) (USD $)	9 Months Ended	3 Months Ended
	Mar. 31, 2014	Mar. 31, 2014	Mar. 31, 2014
		Minimum [Member]	Maximum[Member]
Common stock issuable upon exercise of warrants	1,482,852	'	'
Exercise price	'	$0.90	$1.60
Market price of the Companybs common stock	$2.40	'	'
Risk free interest rate	'	0.44%	0.69%
Dividend yield	'	'	'
Volatility	'	357.70%	381.34%
Expected term	'	'1 year 8 months 28 days	'2 years 11 months 16 days

Derivative_Liabilities_Details1

Derivative Liabilities (Details 1) (USD $)	Mar. 31, 2014		Jun. 30, 2013
Warrant derivative liabilities	$3,530,995		'
Derivative liability	3,530,995	[1],[2]	'	[3]
Fair Value, Inputs, Level 1 [Member]	'		'
Warrant derivative liabilities	'		'
Derivative liability	'		'
Fair Value, Inputs, Level 2 [Member]	'		'
Warrant derivative liabilities	'		'
Derivative liability	'		'
Fair Value, Inputs, Level 3 [Member]	'		'
Warrant derivative liabilities	'		'
Derivative liability	'		'
[1]	California Gold Corp. and Subsidiaries
[2]	Restated
[3]	MV Patents, LLC

Derivative_Liabilities_Details2

Derivative Liabilities (Details 2) (USD $)	2 Months Ended		7 Months Ended
	Mar. 31, 2014		Feb. 06, 2014
Notes to Financial Statements	'		'
Reclassification of warrants to derivative liabilities	'	[1]	'	[2]
Gain on change in fair value of derivative liabilities	2,380,540		'
Derivative liabilities - ending balance	$3,530,995		'
[1]	California Gold Corp. and Subsidiaries
[2]	MV Patents, LLC

Derivative_Liabilities_Details3

Derivative Liabilities (Details Narrative) (USD $)	2 Months Ended		7 Months Ended
	Mar. 31, 2014		Feb. 06, 2014		Feb. 07, 2014
Notes to Financial Statements	'		'		'
Warrants outstanding, derivative liabilities	2,965,704		'		2,965,704
Fair value of warrants outstanding	$3,530,995		'		$1,150,455
Additional derivative warrants issued	40,190,250		'		'
Reclassification of warrants to derivative liabilities	'	[1]	'	[2]	'
Derivative liabilities - ending balance	3,530,995		'		'
Gain on change in fair value of derivative liabilities	$2,380,540		'		'
[1]	California Gold Corp. and Subsidiaries
[2]	MV Patents, LLC

Stock_Options_and_Warrants_Det

Stock Options and Warrants (Details) (USD $)	2 Months Ended
	Mar. 31, 2014
Common Shares Covered by Warrants	'
Outstanding at beginning of period	1,482,852
Granted	590,300
Outstanding at end of period	2,073,152
Exercisable at end of period	2,073,152
Weighted Average Exercise Price	'
Outstanding at beginning of period	$1.09
Granted	$0.50
Outstanding at end of period	$0.92
Exercisable at end of period	0.92
Weighted Average Remaining Term (Years)	'
Outstanding at beginning of period	'2 years 0 months 7 days
Granted	'3 years
Outstanding at end of period	'2 years 1 month 28 days
Exercisable at end of period	'2 years 1 month 28 days
Aggregate Intrinsic Value	'
Outstanding at end of period	4,104,125
Exercisable at end of period	4,104,125

Stock_Options_and_Warrants_Det1

Stock Options and Warrants (Details Narrative)	Mar. 31, 2014
Equity [Abstract]	'
Shares authorized for issuance under equity plan	6,150,564
Options available for grant under plan	6,150,564

Stockholders_Equity_Details_Na

Stockholders' Equity (Details Narrative) (USD $)

1 Months Ended

2 Months Ended

9 Months Ended

33 Months Ended

2 Months Ended

4 Months Ended

7 Months Ended

2 Months Ended

4 Months Ended

7 Months Ended

Feb. 06, 2014

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2014

Jul. 21, 2014

Feb. 06, 2014

Mar. 31, 2014

Jul. 21, 2014

Feb. 06, 2014

Preferred Stock [Member]

Preferred Stock [Member]

Preferred Stock [Member]

Common Stock [Member]

Common Stock [Member]

Common Stock [Member]

Warrants issued with convertible notes cancelled

-3,250,000

'

'

'

'

'

'

'

'

'

'

Right to receive stock acquired issued

4,000,000

'

'

'

'

'

'

'

'

'

'

Proceeds from sale of Preferred A Stock

'

'

'

'

'

$150,000

'

'

'

'

'

Conversion of Preferred stock to common stock, Shares

'

'

'

'

'

-6,000,000

[1]

8,000,000

'

60,000

[1]

80,000

'

Conversion of Preferred stock to common stock, Amount

'

'

[1]

'

'

'

-6,000

[1]

'

'

6,000

[1]

'

'

Stockholder contribution

'

'

$2,757

'

$2,757

'

[1]

'

'

[2]

'

[1]

'

'

[2]

[1]

California Gold Corp. and Subsidiaries

[2]

MV Patents, LLC

Related_Party_Transactions_Det

Related Party Transactions (Details Narrative) (USD $)	Mar. 31, 2014	Jun. 30, 2013
Related Party Transactions [Abstract]	'	'
Accrued Salaries	'	$435,516

Commitments_and_Contingencies_1

Commitments and Contingencies (Details) (USD $)	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
2015	$203,333
2016	143,333
2017	122,431
Employment agreement commitment	$469,097

Commitments_and_Contingencies_2

Commitments and Contingencies (Details Narrative)	2 Months Ended
	Mar. 31, 2014
Commitments and Contingencies Disclosure [Abstract]	'
Commission rate to MV Patents	10.00%

Subsequent_Events_Details_Narr

Subsequent Events (Details Narrative)	2 Months Ended		4 Months Ended
	Mar. 31, 2014		Jul. 21, 2014
Interest owned	'		20.00%
Preferred Stock [Member]	'		'
Conversion of Preferred stock to common stock, Shares	-6,000,000	[1]	8,000,000
Common Stock [Member]	'		'
Conversion of Preferred stock to common stock, Shares	60,000	[1]	80,000
[1]	California Gold Corp. and Subsidiaries

Correction_of_Previously_Repor2

Correction of Previously Reported Information - (Details) (USD $)

2 Months Ended

3 Months Ended

9 Months Ended

12 Months Ended

33 Months Ended

Mar. 31, 2014

Mar. 31, 2014

Mar. 31, 2013

Mar. 31, 2014

Mar. 31, 2013

Jun. 30, 2013

Jun. 30, 2012

Mar. 31, 2014

Derivative liabilities

$3,530,995

[1],[2]

$3,530,995

[1],[2]

'

$3,530,995

[1],[2]

'

'

[3]

'

$3,530,995

[1],[2]

Additional paid-in capital

-238,674

[1],[2]

-238,674

[1],[2]

'

-238,674

[1],[2]

'

'

[3]

'

-238,674

[1],[2]

Deficit accumulated during the development stage

-4,724,476

[1],[2]

-4,724,476

[1],[2]

'

-4,724,476

[1],[2]

'

-1,370,844

[3]

'

-4,724,476

[1],[2]

Total liabilities and stockholders' deficit

2,997,129

[1],[2]

2,997,129

[1],[2]

'

2,997,129

[1],[2]

'

41,023

[3]

'

2,997,129

[1],[2]

Loss from operations

'

1,829,118

[2]

237,667

2,061,880

[2]

578,561

'

'

3,426,602

[2]

Realized and unrealized loss on derivatives

'

-2,380,540

[2]

'

-2,380,540

[2]

'

'

'

-2,380,540

[2]

Total other income (expenses)

'

-2,785,501

[2]

-900

-2,793,842

[2]

-1,908

'

'

-2,799,964

[2]

Loss from continuing operations

'

-4,614,619

[2]

-238,567

-4,855,722

[2]

-580,469

'

'

-6,226,566

[2]

Loss from discontinued operations

'

-212,479

[2]

'

-212,479

[2]

'

'

'

-212,479

[2]

Net loss

-4,724,476

-4,827,098

[2]

-238,567

-5,068,201

[2]

-580,469

-886,877

[3]

-483,967

[3]

-6,439,045

[2]

Scenario, Previously Reported [Member]

'

'

'

'

'

'

'

'

Derivative liabilities

986,905

986,905

'

986,905

'

'

'

986,905

Additional paid-in capital

587,139

587,139

'

587,139

'

'

'

587,139

Deficit accumulated during the development stage

-3,006,199

-3,006,199

'

-3,006,199

'

'

'

-3,006,199

Total liabilities and stockholders' deficit

2,997,129

2,997,129

'

2,997,129

'

'

'

2,997,129

Loss from operations

'

-1,829,118

'

-2,061,880

'

'

'

-3,426,602

Realized and unrealized loss on derivatives

'

-662,263

'

-662,263

'

'

'

-662,263

Total other income (expenses)

'

-1,067,224

'

-1,075,565

'

'

'

-1,081,687

Loss from continuing operations

'

-2,896,342

'

-3,137,445

'

'

'

-4,508,289

Loss from discontinued operations

'

-212,479

'

-212,479

'

'

'

-212,479

Net loss

'

-3,108,821

'

-3,349,924

'

'

'

-4,720,768

Scenario, Adjustment [Member]

'

'

'

'

'

'

'

'

Derivative liabilities

2,544,090

2,544,090

'

2,544,090

'

'

'

2,544,090

Additional paid-in capital

-825,813

-825,813

'

-825,813

'

'

'

-825,813

Deficit accumulated during the development stage

-1,718,277

-1,718,277

'

-1,718,277

'

'

'

-1,718,277

Total liabilities and stockholders' deficit

'

'

'

'

'

'

'

'

Loss from operations

'

'

'

'

'

'

'

'

Realized and unrealized loss on derivatives

'

-1,718,277

'

-1,718,277

'

'

'

-1,718,277

Total other income (expenses)

'

-1,718,277

'

-1,718,277

'

'

'

-1,718,277

Loss from continuing operations

'

-1,718,277

'

-1,718,277

'

'

'

-1,718,277

Loss from discontinued operations

'

'

'

'

'

'

'

'

Net loss

'

-1,718,277

'

-1,718,277

'

'

'

-1,718,277

Scenario, Actual [Member]

'

'

'

'

'

'

'

'

Derivative liabilities

3,530,995

3,530,995

'

3,530,995

'

'

'

3,530,995

Additional paid-in capital

-238,674

-238,674

'

-238,674

'

'

'

-238,674

Deficit accumulated during the development stage

-4,724,476

-4,724,476

'

-4,724,476

'

'

'

-4,724,476

Total liabilities and stockholders' deficit

2,997,129

2,997,129

'

2,997,129

'

'

'

2,997,129

Loss from operations

'

-1,829,118

'

-2,061,880

'

'

'

-3,426,602

Realized and unrealized loss on derivatives

'

-2,380,540

'

-2,380,540

'

'

'

-2,380,540

Total other income (expenses)

'

-2,785,501

'

-2,793,842

'

'

'

-2,799,964

Loss from continuing operations

'

-4,614,619

'

-4,855,722

'

'

'

-6,226,566

Loss from discontinued operations

'

-212,479

'

-212,479

'

'

'

-212,479

Net loss

'

($4,827,089)

'

($5,068,201)

'

'

'

($6,493,045)

[1]

California Gold Corp. and Subsidiaries

[2]

Restated

[3]

MV Patents, LLC